Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of fospropofol disodium versus propofol for induction of general anesthesia
ChiCTR1800016410Phase 3Completed
- Sponsor
- West China Hospital of Sichuan University
- Start
- Apr 2017
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of fospropofol disodium in None (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: MOAA/S sedation and anesthesia score, Central nervous system safety and 4 more. Started Apr 2017; status: completed.
02
Drugs
fospropofol disodium
Beyond the preview
Go deeper on ChiCTR1800016410.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800016410.